Literature DB >> 10711930

QT dispersion as a predictor of acute heart failure after high-dose cyclophosphamide.

H Nakamae, K Tsumura, M Hino, T Hayashi, N Tatsumi.   

Abstract

No useful predictor of risk of acute heart failure in peripheral-blood stem-cell transplantation (PBSCT) regimens, Including high-dose cyclophosphamide, has previously been available. Corrected QT dispersion can predict acute heart failure after high-dose cyclophosphamide chemotherapy used in PBSCT.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10711930     DOI： 10.1016/S0140-6736(00)02051-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  11 in total

1.  Investigation of the effect of hepatic metabolism on off-target cardiotoxicity in a multi-organ human-on-a-chip system.

Authors:  Carlota Oleaga; Anne Riu; Sandra Rothemund; Andrea Lavado; Christopher W McAleer; Christopher J Long; Keisha Persaud; Narasimhan Sriram Narasimhan; My Tran; Jeffry Roles; Carlos A Carmona-Moran; Trevor Sasserath; Daniel H Elbrecht; Lee Kumanchik; L Richard Bridges; Candace Martin; Mark T Schnepper; Gail Ekman; Max Jackson; Ying I Wang; Reine Note; Jessica Langer; Silvia Teissier; James J Hickman
Journal:  Biomaterials       Date:  2018-08-04       Impact factor: 12.479

Review 2.  Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling.

Authors:  M Malik; A J Camm
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

3.  The analysis of the parameters of 24-hr ECG Holter monitoring in patients with blood neoplasms undergoing high-dose chemotherapy and stem cell transplantation.

Authors:  Małgorzata Poręba; Paweł Gać; Lidia Usnarska-Zubkiewicz; Witold Pilecki; Kazimierz Kuliczkowski; Grzegorz Mazur; Małgorzata Sobieszczańska; Rafał Poręba
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-01-24       Impact factor: 1.468

4.  Cyclophosphamide-induced Atrial Fibrillation With Rapid Ventricular Rate.

Authors:  Komal Ejaz; Muhammad A Raza; Shahram Maroof; Muhammad W Haider
Journal:  Cureus       Date:  2018-05-16

Review 5.  Acute Cyclophosphamide Hemorrhagic Myopericarditis: Dilemma Case Report, Literature Review and Proposed Diagnostic Criteria.

Authors:  Subeer Wadia
Journal:  J Clin Diagn Res       Date:  2015-11-01

Review 6.  Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation.

Authors:  Seth J Rotz; Thomas D Ryan; Salim S Hayek
Journal:  J Thromb Thrombolysis       Date:  2020-11-24       Impact factor: 2.300

Review 7.  Cancer therapy and cardiotoxicity: the need of serial Doppler echocardiography.

Authors:  Maurizio Galderisi; Francesco Marra; Roberta Esposito; Vincenzo Schiano Lomoriello; Moira Pardo; Oreste de Divitiis
Journal:  Cardiovasc Ultrasound       Date:  2007-01-25       Impact factor: 2.062

8.  Cyclophosphamide-Induced Cardiomyopathy: A Case Report, Review, and Recommendations for Management.

Authors:  Sumandeep Dhesi; Michael P Chu; Gregg Blevins; Ian Paterson; Loree Larratt; Gavin Y Oudit; Daniel H Kim
Journal:  J Investig Med High Impact Case Rep       Date:  2013-01-01

9.  Mangiferin protects rat myocardial tissue against cyclophosphamide induced cardiotoxicity.

Authors:  Laxit Bhatt; Binu Sebastian; Viraj Joshi
Journal:  J Ayurveda Integr Med       Date:  2017-06-10

10.  Electrocardiographic Characteristics of Breast Cancer Patients Treated with Chemotherapy.

Authors:  Xufei Liang; Yueying Wang; Xi Yin; Xiaohong Gong; Shuo Pan; Ziliang Chen; Xuhong Geng
Journal:  Cardiol Res Pract       Date:  2020-12-09       Impact factor: 1.866
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.